Detalhe da pesquisa
1.
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Cell Rep Med
; 5(3): 101469, 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38508137
2.
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.
Front Immunol
; 14: 1301100, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38149253
3.
Effects of Regulatory T Cell Depletion in BALB/c Mice Infected with Low Doses of Borrelia burgdorferi.
Pathogens
; 12(2)2023 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36839461